Kaplan-Meier estimates of treatment outcomes for CML-CP patients randomized to DAS (1) or IM (2) therapy. Tickmarks indicate censored observations. Numbers remaining at risk are shown beneath each plot. (A) Overall survival. (B) Progression-free survival. (C) Relapse-free survival of patients who achieved complete hematologic remission.